Implementing Ac-225 labelled radiopharmaceuticals: practical considerations and (pre-)clinical perspectives

Implementing Ac-225 labelled radiopharmaceuticals: practical considerations and (pre-)clinical perspectives

Abstract Background In the past years, there has been a notable increase in interest regarding targeted alpha therapy using Ac-225, driven by the observed promising clinical anti-tumor effects. As the production and technology has advanced, the availability of Ac-225 is expected to increase in the n...

Full description

Bibliographic Details
Main Authors: Eline L. Hooijman, Valery Radchenko, Sui Wai Ling, Mark Konijnenberg, Tessa Brabander, Stijn L. W. Koolen, Erik de Blois
Format: Article
Language:English
Published: SpringerOpen 2024-02-01
Series:EJNMMI Radiopharmacy and Chemistry
Subjects:
Targeted alpha therapy (TAT)
Targeted radionuclide therapy (TRT)
Radiolabelling
Actinium-225
Quality control
Practical implementation
Online Access:https://doi.org/10.1186/s41181-024-00239-1

Internet

https://doi.org/10.1186/s41181-024-00239-1

Similar Items